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Introduction
The cytokine cardiotrophin-1 (CT-1) is a member of the IL-6
family of cytokines acting through the heterodimeric complex
LIFR:gp130 that becomes tyrosine phosphorylated by Janus
kinases (Jaks). The Jaks activate multiple downstream
signalling pathways, which involve signal transducers and
activators of transcription (STATs), MAPKs, PI3-kinase and
NF-B (Freed et al., 2005; Pennica et al., 1996). Several
biological effects with vital importance on heart development
and function have been attributed to CT-1. In embryonic and
neonatal cardiomyocytes CT-1 has been demonstrated to
mediate cell proliferation and support cell survival (Sheng et
al., 1996). In ES cells CT-1 has been recently shown to
stimulate cardiomyogenic differentiation and cell proliferation
by a mechanism involving ROS as signalling molecules in
Jak/STAT-, MAPK- and NF-B-mediated signal transduction
cascades (Sauer et al., 2004). Besides its important function in
embryonic and neonatal tissues CT-1 exerts a protective
function in the adult heart by inducing cell hypertrophy
through stimulation of sarcomere assembly in series with the
subsequent increase in cardiomyocyte cell length (Wollert et
al., 1996), and by preventing apoptosis in vitro and in vivo
(Sheng et al., 1997). Furthermore, CT-1 has been shown to
stimulate cardiac fibroblast proliferation and migration,
thereby allowing repopulation of scars developing after cardiac
infarction with cells that promote wound healing and preserve
cardiac function (Freed et al., 2003).
So far, the molecular regulation of CT-1 expression is
unknown. The properties of CT-1 as a cardioprotective
cytokine in stress conditions predict upregulation during
cardiac diseases that are characterized by an environment of
hypoxia, inflammation and oxidative stress. It could be
hypothesized that stress stimuli occurring during cardiac
diseases regulate the expression of CT-1, which subsequently
exerts its cardioprotective effect. In this respect it has been
demonstrated that CT-1 is cardioprotective for ischemia-
reperfusion injury, even when added late during reoxygenation
(Brar et al., 2001; Liao et al., 2002), and it was discussed that
early expression of CT-1 in the ischemic myocardium may
represent an adaptive, protective phenomenon that is beneficial
in reducing myocyte loss and inducing hypertrophy of
remaining myocytes, thereby allowing the maintenance of
overall ventricular function (Freed et al., 2005). Indeed
elevated serum levels of CT-1 have been observed in patients
with unstable angina pectoris (Talwar et al., 2000a), acute
myocardial infarction (Freed et al., 2003; Talwar et al., 2000b)
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expression is regulated by reactive oxygen species (ROS)
and hypoxia. Treatment with either prooxidants or
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and heart failure (Talwar et al., 2000b). A comparable
microenvironment of hypoxia and elevated ROS generation
may prevail in the heart of the early postimplantation embryo
and could regulate CT-1 expression in the embryonic heart.
Hypoxia and robust endogenous ROS production have been
previously shown to occur in differentiating ES cells and may
represent one key stimulus for regulation of CT-1 expression
as well as induction of the cardiomyogenic cell lineage (Sauer
et al., 2000).
The current study was performed to evaluate the impact of
the stress factors hypoxia and ROS on the signalling cascades
resulting in CT-1 expression. Since differentiating ES cells
within embryoid bodies mimic cardiomyogenic differentiation
(Desbaillets et al., 2000), and knowing that vascularized
embryoid bodies are well oxygenated (Gassmann et al., 1996),
we made use of this cell culture model. Our data indicate that
hypoxia as well as ROS use a common HIF-1-regulated
signalling pathway that results in increased CT-1 expression.
HIF-1 is a heterodimer composed of the constitutively
expressed -subunit and the oxygen-dependent -subunit
(HIF-1) that is stabilized under hypoxic conditions (reviewed
by Hopfl et al., 2004). Comparable situations of hypoxia and
oxidative stress occur in various stress conditions and
presumably mediate cardioprotection as well as cardiac cell
proliferation and hypertrophy by CT-1 in the embryonic and
adult heart.
Results
Increasing CT-1 and gp130 expression in differentiating
wt ES cells
We recently showed that treatment of ES-cell-derived
embryoid bodies with CT-1 results in stimulation of
cardiomyogenesis, and that CT-1 is endogenously expressed in
embryoid bodies (Sauer et al., 2004). To correlate CT-1 with
the time course of embryoid body differentiation and
expression of the transducing receptor gp130, protein levels of
CT-1 and gp130 were monitored. Expression of CT-1 (n=6) and
gp130 (n=4) followed a similar expression pattern until day 8
in culture and subsequent downregulation on day 10 and day
11 (Fig. 1A,B). Expression of CT-1 and gp130 culminated at
175±25% and 188±6%, respectively, on day 8 compared with
day 2 (set to 100%). It has been previously shown that
cardiomyogenic differentiation of mouse ES cells occurs
between day 6 and 8, i.e. during the time of maximal CT-1 and
gp130 expression (Hescheler et al., 2002).
Regulation of CT-1 and HIF-1 expression by vitamin E
We have previously shown that differentiating embryoid bodies
express HIF-1 (Bichet et al., 1999) and robustly generate
ROS that may be used as signalling molecules regulating CT-
1 expression (Sauer et al., 2000). To support this assumption,
embryoid bodies were treated with the free radical scavenger
vitamin E (20 M) from day 2 to day 8 (Fig. 2). Subsequently,
CT-1 expression was assessed in untreated and vitamin-E-
treated embryoid bodies. Since CT-1 has been previously
shown to be upregulated by hypoxic stress in cardiac myocytes
(Hishinuma et al., 1999) the expression of HIF-1 was
Journal of Cell Science 119 (6)
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Fig. 1. Protein expression of CT-1 (A) and gp130 (B) during of ES
cell differentiation. Determination was performed within the three-
dimensional tissue of embryoid bodies. Note that cardiac cell
differentiation occurs during day 6 and 8 of embryoid body cell
culture (Hescheler et al., 2002). *P<0.05, significantly different to
levels at day 1 and day 2 of cell culture in A and B, respectively.
Fig. 2. Regulation of CT-1 and HIF-1 expression in embryoid
bodies by endogenous ROS. Embryoid bodies were incubated from
day 2 to day 8 of cell culture with 20 M vitamin E. On day 8
protein expression of CT-1 and HIF-1 was assessed by
semiquantitative immunohistochemistry in whole-mount embryoid
bodies. The images show representative embryoid bodies labeled
with antibodies either against CT-1 or HIF-1 which remained
untreated (a,c) or were treated with vitamin E (b,d). *P<0.05,
significantly different to levels in the untreated control.
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assessed in parallel to investigate possible correlation with
CT-1 expression. It was apparent that vitamin E treatment
downregulated CT-1 as well as HIF-1 expression in 8-day-
old embryoid bodies (untreated control set to 100%), indicating
regulation by ROS endogenously generated in differentiating
ES cells (n=4). Assessment of the effects of vitamin E
following 24 hours and 72 hours of incubation revealed that
HIF-1 and CT-1 were downregulated in parallel (data not
shown).
Regulation of CT-1 and HIF-1 expression by
exogenous prooxidants
The data above suggest that regulation of CT-1 and HIF-1
occurs by endogenous generation of ROS during
differentiation. To validate these findings, 4-day-old embryoid
bodies were treated with either the prooxidants menadione or
H2O2 (Fig. 3A,B). Treatment of embryoid bodies with H2O2 in
concentrations ranging from 1 nM to 100 M resulted in the
dose-dependent increase of CT-1 protein expression (data not
shown). Maximum effects were achieved at 10 M H2O2,
which increased CT-1 protein (Fig. 3A) and mRNA expression
(Fig. 3B) to 145±8% and 140±9%, respectively (n=3)
(untreated control set to 100%). Likewise, treatment with 10
M (data not shown) and 20 M menadione resulted in
increased CT-1 expression with maximum values of 157±8 %
and 175±7% for CT-1 protein (n=3) (Fig. 3A) and mRNA
(n=3) (Fig. 3B) expression, respectively, at 20 M menadione
concentration. Under the same experimental conditions
increased protein as well as mRNA expression of HIF-1 was
observed. HIF-1 protein expression amounted to 140±8% and
184±9% (see Fig. 3A), and mRNA expression to 220±24% and
264±7% for H2O2 and menadione, respectively (see Fig. 3B)
(n=5), thus corroborating the notion of parallel regulation of
CT-1 and HIF-1 by prooxidants.
Upregulation of CT-1 and HIF-1 expression by hypoxia
Regulation of CT-1 on the protein as well as mRNA level
paralleled the regulation of HIF-1. Consequently, it should be
hypothesized that hypoxia results in the reverse situation:
upregulation of CT-1. To address this assumption, 4-day-old
embryoid bodies were exposed to either 24 hours of
physiological (1% O2) or chemical (50 M CoCl2) hypoxia
Fig. 3. Upregulation of CT-1 and HIF-1 protein and mRNA upon treatment with prooxidants and hypoxia. (A,B) Embryoid bodies were
treated on day 4 with menadione (20 M) and H2O2 (10 M). Protein (A) and mRNA (B) levels were examined 24 hours later. The images
above A show representative embryoid bodies labeled with antibodies against CT-1 (left panel) and HIF-1 (right panel) which remained
either untreated (a,d) or were treated with menadione (b,e) or H2O2 (c,f). (C,D) Embryoid bodies were treated on day 4 of cell culture with
either physiological (1% O2) or chemical (CoCl2) hypoxia and protein (C) and mRNA (D) levels were examined 24 hours later. The images
above C show representative embryoid bodies labeled with antibodies against CT-1 (left panel) and HIF-1 (right panel) which remained
either untreated (a,d) or were treated with 1% O2 (b,e) or CoCl2 (50 M) (c,f). *P<0.05, levels are significantly different to those in the
untreated controls. Bars, 200 m.
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(Fig. 3C,D). Physiological (n=3) as well as chemical hypoxia
(n=4) upregulated CT-1 protein expression to 191±18% and
157±13%, respectively, whereas increased levels of HIF-1
protein amounting to 192±20% (n=3) and 183±16% (n=3)
were observed upon physiological and chemical hypoxia,
respectively (see Fig. 3C). A significant increase in CT-1 as
well as HIF-1mRNA expression amounting to 192±8% (n=3)
and 279±24% (n=4), respectively, was only achieved with
chemical hypoxia. Assessment of the time course of HIF-1
and CT-1 expression upon treatment with either menadione
(Fig. 4A) (n=3) or CoCl2 (Fig. 4B) (n=4) revealed that
upregulation occurred after only 2 hours of incubation.
Statistical significance was achieved at earlier time points for
HIF-1 expression compared with CT-1 expression, i.e. after
2 and 4 hours in menadione and CoCl2-treated samples,
respectively, suggesting that HIF-1 precedes CT-1 expression.
Journal of Cell Science 119 (6)
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Fig. 4. Time course of HIF-1 and CT-1 upregulation upon treatment with either menadione (A) or CoCl2 (B). Protein expression was assessed
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Fig. 5. Generation of ROS following exposure to menadione or chemical hypoxia (CoCl2 treatment). (A) Embryoid bodies were treated for 24
hours with 20 M menadione. Subsequently, the cell culture medium was exchanged with medium devoid of menadione, and ROS were
monitored at different times after removal of menadione. (B) ROS generation in the presence of either menadione (20 M) or CoCl2 (50 M).
Determination was performed immediately after exposure. The upregulation of CT-1 by menadione (C) and CoCl2 (D) was inhibited by either
the free radical scavenger vitamin E (20 M) or NMPG (20 M). Embryoid bodies were treated at day 4 of cell culture with either menadione
(20 M) or CoCl2 (50 M) in the presence of free radical scavengers. After 24 hours CT-1 protein expression was determined by
semiquantitative immunohistochemistry. *P<0.05, significantly different to levels in the relative controls. #P<0.05, significantly different to
levels in the CoCl2 or menadione-treated samples before addition of scavengers.
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Generation of ROS by menadione and chemical hypoxia
in embryoid bodies
Prooxidants as well as chemical hypoxia may increase
intracellular ROS generation. When embryoid bodies were
treated for 24 hours with 20 M menadione, a significant
increase in ROS generation was observed which remained at
an elevated level 24 hours after replacement into normal
medium, but was not significantly different from the control
after 4 hours (Fig. 5A) (n=4). An increase in ROS generation
was likewise achieved when embryoid bodies were treated for
24 hours with CoCl2 (Fig. 5B) (n=3), suggesting that ROS may
indeed act as signalling molecules regulating the expression
of CT-1 and HIF-1 following treatment with menadione
and chemical hypoxia. This was further corroborated by
experiments where CT-1 expression following treatment with
menadione (Fig. 5C) (n=3) and CoCl2 (Fig. 5D) (n=4) was
assessed in the presence of the free radical scavengers vitamin
E (20 M) and NMPG (20 M) which resulted in significant
downregulation of CT-1 expression, thus indicating regulation
of CT-1 expression by intracellular ROS.
Upregulation of NADPH oxidase in embryoid bodies by
menadione and hypoxia
Prooxidants may regulate the expression of ROS generating
NADPH oxidase thereby providing a feed-forward loop of
increased ROS generation even in the absence of external
prooxidants. To evaluate this idea, we determined expression
of NADPH oxidase subunits. Preincubation for 24 hours with
either menadione (20 M) or CoCl2 (50 M) significantly
increased protein expression of p22-phox, p47-phox, p67-
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Fig. 6. Upregulation of NADPH oxidase subunits upon incubation of embryoid bodies with menadione and CoCl2. (A) Protein expression of
the NADPH oxidase subunits p22-phox, p47-phox, p69-phox, Nox-1 and Nox-4 which was determined 24 hours after treatment of 4-day-old
embryoid bodies by semiquantitative immunohistochemistry. (B) mRNA expression of Nox1 and Nox4 upon either menadione (20 M) or
CoCl2 (50 M) treatment. (C) The upregulation of CT-1 by menadione and CoCl2 was inhibited by preincubation with the NADPH oxidase
inhibitors DPI (10 M) or apocynin (10 M). Embryoid bodies were treated at day 4 of cell culture with either menadione (20 M) or CoCl2
(50 M) in the presence of either DPI or apocynin. After 24 hours, CT-1 protein expression was determined by semiquantitative
immunohistochemistry. The micrographs are representative embryoid bodies either untreated (a), or treated with menadione (b), CoCl2 (c), DPI
(d), DPI + menadione (e), DPI + CoCl2 (f), apocynin (g), apocynin + menadione (h), apocynin + CoCl2 (i). *P<0.05, significantly different
from levels in the control. #P<0.05, significantly different to levels in menadione- and CoCl2-treated samples before addition of inhibitors. Bar,
400 m.
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phox, Nox-1 and Nox-4 (Fig. 6A) (n=4) as well as mRNA
expression of Nox1 and Nox4 (Fig. 6B) (n=5), suggesting
regulation of CT-1 expression by NADPH oxidase-derived
ROS. Furthermore, treatment with physiological hypoxia (1%
O2) significantly increased protein expression of p22-phox,
p47-phox and Nox-4 (data not shown). The involvement of
NADPH oxidase in the regulation of CT-1 expression was
further confirmed by incubating embryoid bodies with either
menadione (20 M) or CoCl2 (50 M) in the presence of the
NADPH oxidase inhibitors DPI (10 M) (n=3) or apocynin (10
M) (n=3) (Fig. 6C). This treatment significantly inhibited the
increase in CT-1 expression following treatment with either
menadione or CoCl2, thus indicating that NADPH oxidase-
derived ROS are involved in upregulation of CT-1 by
prooxidants and hypoxia.
Expression and phosphorylation of gp130 in embryoid
bodies by prooxidants and chemical hypoxia
Regulation of CT-1 expression may be mediated through
phosphorylation of the gp130 signal transduction receptor. To
assess changes in gp130 expression as well as gp130
phosphorylation in the presence of prooxidants and chemical
hypoxia, semiquantitative immunohistochemistry was
performed using antibodies against the unphosphorylated as
well as the phosphorylated form of gp130. It was found that
prooxidants as well as chemical hypoxia significantly
increased gp130 expression as well as phosphorylation,
suggesting activation of gp130-mediated signal transduction
cascades (n=3) (Fig. 7A).
Signalling cascades involved in the upregulation of CT-1
in embryoid bodies by menadione and chemical hypoxia
Upon binding of CT-1 to a LIFR-:gp130 heterodimer a
complex signalling cascade is activated which involves the
MAPK members ERK1,2, JNK and p38 as well as PI3-kinase
and the Jak/STAT pathway. By using phospho-specific
antibodies it was found that phosphorylation of ERK1,2
(menadione, n=3; CoCl2, n=5), JNK (menadione, n=3; CoCl2,
n=5), p38 (menadione, n=4; CoCl2, n=4), and PI3-kinase (n=4)
occurred (Fig. 7B). To correlate the activation of MAPK
pathways and PI3-kinase to the expression of CT-1, embryoid
bodies were treated with the ERK1,2 inhibitor UO126 (10
M), the JNK inhibitor SP600125 (10 M) the p38 inhibitor
SKF86002 (10 M) as well as the PI3-kinase inhibitor
LY294002 (20 M) which significantly downregulated the
menadione- and CoCl2-induced upregulation of CT-1 (n=3)
(Fig. 7C). A comparable inhibition of CT-1 expression was
achieved when the Jak/STAT signalling pathway was inhibited
with the Jak-2 antagonist AG490 (data not shown).
Absence of cardiomyogenesis and stimulation of CT-1
expression in HIF-1–/– ES cells
Menadione- and hypoxia-regulated CT-1 expression in ES cells
should be absent upon inactivation of HIF-1. To test this notion,
embryoid bodies grown from the parental CCE cell line were
treated with the HIF-1 inhibitor 2-ME (3 M). In
Journal of Cell Science 119 (6)
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Fig. 7. Upregulation of gp130 leads to a complex signalling cascade
upon treatment of embryoid bodies with prooxidants or chemical
hypoxia. (A) Embryoid bodies were treated at day 4 of cell culture
with either H2O2 (10 M), menadione (20 M) or CoCl2 (50 M).
After 24 hours, gp130 protein expression and phosphorylation was
assessed by quantitative immunohistochemistry using an antibody
directed against unphosphorylated gp130 or the phosphorylated form
of gp130. (B) Activation of ERK1,2, JNK p38 and PI3-kinase upon
incubation of embryoid bodies with either menadione (20 M) or
CoCl2 (50 M). Activation was assessed by semiquantitative
immunohistochemistry using phospho-specific antibodies. Maximum
activation of ERK1,2 was achieved after 15 minutes; maximum
activation of JNK was at 15 minutes for menadione treatment and 30
minutes for CoCl2 treatment; maximum activation of p38 was at 30
minutes for menadione treatment and 60 minutes for CoCl2
treatment; maximum activation of PI3-kinase was at 60 minutes. (C)
Inhibition of menadione- and CoCl2-mediated upregulation of CT-1
by the ERK1,2 inhibitor UO126 (10 M), the JNK inhibitor
SP600125 (10 M), the p38 inhibitor SKF86002 (10 M), and the
PI3-kinase inhibitor LY294002 (20 M). Embryoid bodies were
treated at day 4 of cell culture with either menadione (20 M) or
CoCl2 in the presence of the respective inhibitor. CT-1 protein
expression was assessed after 24 hours by semiquantitative
immunohistochemistry. *P<0.05, significantly different from levels
in the untreated control; #P<0.05, significantly different to levels
before addition of inhibitors as indicated.
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corroboration of our working hypothesis it was apparent that
in the presence of 2-ME menadione- and chemical hypoxia-
induced upregulation of CT-1 was significantly attenuated (Fig.
8) (n=5). Furthermore, treatment with 2-ME significantly
inhibited the increase in HIF-1 expression observed after
menadione (20 M) exposure (data not shown). To prove the
involvement of HIF-1, we made use of our homozygous HIF-
1-deficient HM ES cell line (Hopfl et al., 2002). In
differentiating HIF-1–/– ES cells cardiomyogenesis was
completely absent as assessed by determination of the number
of beating embryoid bodies (see Fig. 9A). Moreover, compared
with wild-type HM-1 ES cells (see Fig. 9B) and ES cells of
the CCE cell line (see Fig. 1A) no upregulation of CT-1 during
the time course of differentiation was observed (n=5).
Furthermore, the upregulation of CT-1 mRNA (see Fig. 9C)
(n=6) and protein (see Fig. 9D) (n=4) following treatment of
embryoid bodies with menadione and CoCl2 was completely
abolished in HIF-1–/– ES cells. Taken together, our data
strongly support the hypothesis that HIF-1 regulates CT-1
expression.
Discussion
Hypoxia is a (patho)physiological situation occurring during
conditions where increased expression of CT-1 has been
reported: (1) during cardiac diseases like angina pectoris,
cardiac infarction and heart failure (Freed et al., 2003); (2) in
the embryonic heart where the heart mass increases through
cardiac cell hyperplasia (Wikenheiser et al., 2005); (3) during
the growth of ES cells within the three-dimensional tissue of
embryoid bodies (Wartenberg et al., 2001). Recently, it has
been demonstrated that hypoxia is associated with increased
ROS generation produced either through the mitochondrial
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respiratory chain or NADPH oxidase activity (Wolin et al.,
2005). Elevated ROS are known to occur in cardiac infarction
and are suspected to cause ischemia-reperfusion injury (Berg
et al., 2005).
Hypoxia has been previously demonstrated to induce CT-1
expression (Hishinuma et al., 1999). Hypoxia occurs in
differentiating ES cells within embryoid bodies (Wartenberg et
al., 2001) and ROS are generated via NADPH oxidase (Sauer
et al., 2000; Sauer et al., 1999), suggesting that hypoxia and
ROS may regulate CT-1 expression. Consequently, incubation
of ES-cell-derived embryoid bodies with free radical
scavengers downregulated CT-1 and HIF-1 expression; by
contrast, prooxidants as well as physiological and chemical
hypoxia upregulated CT-1 as well as HIF-1 protein and
mRNA expression. Furthermore, either menadione treatment
or chemical hypoxia resulted in increased ROS generation with
subsequent upregulation of ROS-generating NADPH oxidase,
supporting the notion that the same ROS-mediated signaling
pathways are triggered under conditions of prooxidant
incubation and hypoxia.
Elevated ROS levels during hypoxia have been previously
shown to occur in pulmonary myocytes (Marshall et al., 1996),
cardiac myocytes, Hep3B cells, HeLa cells (Chandel et al.,
1998) as well as adipocytes (Carriere et al., 2003); the sources
being either the mitochondrial respiratory chain or NADPH
oxidase. The data of the present study clearly indicate a distinct
role of NADPH oxidase-derived ROS in the regulation of CT-
1 expression in ES cells (see Fig. 10) because inhibition of
NADPH oxidase by apocyin as well as DPI abolished
prooxidant and chemical hypoxia-mediated induction of CT-1.
The involvement of ROS in the regulation of CT-1 expression
was further validated by experiments demonstrating that the
effects observed with the prooxidant menadione and chemical
hypoxia were significantly inhibited in the presence of free
radical scavengers.
The regulation of cytokine expression by HIF-1 and ROS
has been recently discussed (Haddad and Harb, 2005).
Previously, stimulation of mRNA expression as well as
secretion of IL-6 in response to exposure with prooxidants has
been shown (Kosmidou et al., 2002; Kida et al., 2005; Haddad,
2002) and may act in paracrine as well as autocrine manner,
thereby activating a loop mechanism disposed to stimulate the
IL-6 receptors of the cell. In this respect, the data of the current
study demonstrated stimulation of gp130 protein expression as
well as phosphorylation by prooxidants and chemical hypoxia,
and downstream activation of several members of the
previously described (Heinrich et al., 2003), CT-1 activated
signal transduction cascade, i.e. the MAPKs ERK1,2, JNK,
p38 as well as PI3-kinase, which indeed suggests activation of
the CT-1-mediated signaling cascade by ROS (see Fig. 10).
Consequently, the data of the present study demonstrated that
inhibition of all investigated MAPK pathways, PI3-kinase as
well as the Jak/STAT pathway, abolished the prooxidant- and
hypoxia-mediated increase in CT-1 and HIF-1 expression.
The mouse CT-1 gene has been recently isolated. It
constitutes 5.4 kilobases (kb) in length and consists of three
exons and two introns. When nucleotide sequences of the
coding regions of exons were compared with those of the
human gene, it was observed that exon 1, 2 and 3 share 96%,
84% and 81% homology, respectively. Interestingly, potential
binding sites for several ubiquitous transcription factors
including HIF-1 were present in the 5–flanking region
extending 2174 bp upstream from the transcription initiation
site (Funamoto et al., 2000).
If CT-1 expression is indeed regulated by HIF-1, absence of
hypoxia- and prooxidant-mediated upregulation of CT-1
should be anticipated under conditions of either
pharmacological or genetic inactivation of the  subunit of
HIF-1. This was investigated by either a pharmacological
approach using 2-ME, which has been recently shown to
downregulate HIF-1 at the posttranscriptional level and
inhibits HIF-1-induced transcriptional activation of VEGF
expression (Mabjeesh et al., 2003), or by ES cells homozygous
deficient for HIF-1 (Hopfl et al., 2002). Although basal
mRNA and protein expression of CT-1 was found in HIF-1–/–
cells (data not shown), upregulation during the time course of
ES cell differentiation as occurs in wild-type cells was not
observed, and cardiomyogenesis was completely absent.
Furthermore, prooxidants as well as chemical hypoxia failed
to upregulate CT-1 in HIF-1–/– ES cells which clearly
demonstrates regulation of CT-1 expression by HIF-1.
Although the classical view of HIF-1 regulation proposed
stabilization of HIF-1 under hypoxic conditions and
downregulation at normoxia by the pVHL-mediated ubiquitin-
proteasome pathway, mechanisms of HIF-1 stabilization
under normoxic conditions have been recently proposed (Lee
et al., 2004). These non-hypoxic pathways are used by many
growth factors and cytokines, including insulin-like growth
factors (Feldser et al., 1999), transforming growth factor and
platelet-derived growth factor (Gorlach et al., 2001) and IL-1
(Hellwig-Burgel et al., 1999), which are all known to utilize
ROS as signaling molecules within their signal transduction
cascade. In this regard it was demonstrated that inhibition of
Journal of Cell Science 119 (6)
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ROS generation abolished hormone and growth-factor-
mediated increases in HIF-1 (Richard et al., 2000). The data
of the present study demonstrate ROS generation under
conditions of either chemical or physiological hypoxia which
was recently also reported to occur in intrapulmonary arteries
of mice (Liu et al., 2005), in skeletal muscle (Zuo and Clanton,
2005) and in human hepatoma cells (Chandel et al., 2000). This
was underscored by the observation that oxygen sensing during
hypoxia is dependent on mitochondrial-generated ROS
(Brunelle et al., 2005; Emerling et al., 2005). 
Regulation of CT-1 expression by HIF-1 and ROS sounds
reasonable in light of its biological function in inhibiting
cardiac cell apoptosis, promoting cardiac cell hypertrophy
and stimulating embryonic cardiac cell differentiation and
proliferation which are phenomena occurring under conditions
of hypoxia and/or ROS-mediated inflammation. Investigation
of the physiological microenvironment that regulates CT-1
expression will not only help us to uncover the role of CT-1 in
cardiac hypertrophy and cardiac repair in the infarcted heart,
but will also help us to understand the mechanisms of cardiac
cell hyperplasia in the embryonic heart and cardiomyogenic
differentiation of ES cells.
Materials and Methods
Materials
N-(2-mercapto-propionyl)-glycine NMPG, 2-methoxyestradiol (2-ME),
diphenylene iodonium chloride (DPI) and apocynin were purchased from Sigma,
Deisenhofen, Germany. Trolox (water-soluble vitamin E), UO126, SP600125,
SKF86002, LY294002 and AG490 were from Calbiochem (Bad Soden, Germany).
Spinner-culture technique for cultivation of embryoid bodies
To obtain embryoid bodies, ES cell lines CCE, HM-1 wild type (wt) and HM-1
homozygous deficient for HIF-1 (HIF-1–/–) (Hopfl et al., 2002) were grown on
mitotically inactivated feeder layers of primary murine embryonic fibroblasts for a
maximum of eight passages in Iscove’s medium (Gibco, Life Technologies,
Helgerman Court, MD) supplemented with 18% heat-inactivated (56°C, 30 minutes)
fetal calf serum (FCS) (Sigma), 2 mM Glutamax, (PAA, Cölbe, Germany), 100 M
-mercaptoethanol (Sigma, Deisenhofen, Germany), 1% (v/v) NEA non-essential
amino acids stock solution (100) (Biochrom), 0.8% (v/v) MEM amino acids
(50) (Biochrom), 1 mM  sodium pyruvate (Biochrom), 0.25% (v/v)
penicillin/streptomycin (200) (Biochrom) and 1000 U/ml LIF (Chemicon,
Hampshire, UK) in a humidified environment containing 5% CO2 at 37°C, and
passaged every 2-3 days. At day 0 of differentiation adherent cells were
enzymatically dissociated using 0.2% trypsin and 0.05% EDTA in phosphate-
buffered saline (PBS) (Gibco), and seeded at a density of 1107 cells/ml in 250 ml
siliconized spinner flasks (Integra Biosciences, Fernwald, Germany) containing 100
ml Iscove’s medium supplemented with the same additives as described above. After
24 hours, 150 ml medium was added to give a final volume of 250 ml. The spinner
flask medium was stirred at 20 rpm using a stirrer system (Integra Biosciences) and
150 ml cell culture medium was exchanged every day.
Immunohistochemistry
Immunohistochemistry was performed with whole-mount embryoid bodies. As
primary antibodies a rat anti-mouse CT-1 monoclonal antibody (1:100) (R&D
Systems, Wiesbaden, Germany), a mouse anti-mouse HIF-1 monoclonal antibody
(1:100) (R&D Systems), a goat anti-mouse gp130 antibody (1:100) (R&D Systems),
a phosphospecific polyclonal goat anti-mouse p-gp130 antibody (1:100) (Santa Cruz
Biotechnologies, Santa Cruz, CA), polyclonal goat anti-mouse Mox-1 (Nox-1),
Nox-4, p22-phox, p47-phox, and rabbit anti-mouse p67-phox antibodies (1:50) (all
from Santa Cruz), rabbit polyclonal anti-ERK1,2, anti-JNK, anti-p38 and PI3-kinase
P85 antibodies (1:50) directed against the active (phosphorylated) form of the
proteins (all from New England Biolabs, Frankfurt, Germany), were used. For HIF-
1, CT-1, gp130, p-gp130, Mox-1, Nox-4, p22-phox and p-67-phox staining the
respective tissues were fixed in ice-cold methanol for 30 minutes at –20°C, and
washed with PBS containing 0.1% Triton X-100 (PBST) (Sigma). For PI3-kinase
P85, p-p38, p-ERK1,2 and p-JNK staining the tissues were fixed for 1 hour at 4°C
in 4% formaldehyde in PBS. Blocking against nonspecific binding was performed
for 60 minutes with 10% FCS dissolved in 0.01% PBST. The tissues were
subsequently incubated overnight at 4°C with primary antibodies dissolved in PBS
supplemented with 10% FCS in 0.1% PBST. The tissues were then washed three
times with PBST (0.01% Triton) and reincubated with either a Cy5-conjugated goat
anti-rat IgG (H+L), a Cy5-conjugated goat anti-mouse IgG (H+L), or a Cy5-
conjugated goat anti-rabbit IgG (all from Dianova, Hamburg, Germany) at a
concentration of 3.8 g/ml in PBS containing 10% FCS in 0.01% PBST. After
washing three times in PBST (0.01% Triton) the tissues were stored in PBS until
inspection. Fluorescence was recorded using a confocal laser-scanning setup
(LSM510 Meta, Carl Zeiss, Germany) connected to an inverted microscope
(Axiovert 200M, Carl Zeiss). The confocal setup was equipped with a 5 mW
helium/neon laser, single excitation 633 nm (excitation of Cy5). Emission was
recorded at >665 nm. The pinhole settings of the confocal setup were adjusted to
give a full-width half maximum (FWHM) of 10 m. Fluorescence was recorded in
a depth of 80-120 m in the depth of the tissue and the fluorescence values in the
respective optical section were evaluated by the image analysis software of the
confocal setup.
Quantitative RT-PCR
Total RNA from CCE and HM-1 embryoid bodies treated for 24 hours with the
substances as indicated was prepared using Trizol (Invitrogen) followed by genomic
DNA digestion using DNAse I (Invitrogen, Karlsruhe, Germany). Total RNA
concentration was determined by measuring OD260nm. cDNA synthesis was
performed using 2 g RNA in a total volume of 20 l with MMLV RT (Invitrogen).
Primer concentration for qPCR was 10 pM/20 l. Primer (Invitrogen) sequences
were as follows: HIF-1, 5-TCA CCA GAC AGA GCA GGA AA-3 and 5-CTT
GAA AAA GGG AGC CAT CA-3; CT-1, 5-GAA CAC ACA GGA CAC AGA
TGG AG-3 and 5-GAA CAC ACA GGA CAC AGA TGG AG-3; NOX1, 5-AAT
GCC CAG GAT CGA GGT-3 and 5-GAT GGA AGC AAA GGG AGT GA-3;
NOX4, 5-GAT CAC AGA TCC CTA GCA G-3 and 5-GTT GAG GGC ATT CAC
CAA GT-3. Primer sequences for house keeping genes were: BACT, 5-GAT GAC
CCA GAT CAT GTT TGA G-3 and 5-CCA TCA CAA TGC CTG TGG TA-3;
GAPDH, 5-TCG TCC GGT AGA CAA AAT GG-3 and 5-GAG GTC AAT GAA
GGG GTC GT-3.
Amplifications were performed in an Icycler Optical Module (Biorad, Munich,
Germany) using iQTM SYBR Green Supermix (Biorad) at 95°C for 15 minutes, 45
cycles of 95°C for 30 seconds and the specific annealing temperatures for 30
seconds then 72°C for 30 seconds and a final extension at 50°C for 10 minutes.
Annealing temperatures were 60°C for HIF-1, Nox-1 and BACT, and 64°C for
CT-1, Nox-4 and GAPDH. HIF-1 and Nox-1 data were normalized against the -
actin (BACT) signal, and CT-1 and Nox-4 data were normalized against the GAPDH
signal. The primer concentration was 10 pM/20 l. Fluorescence increase of SYBR
Green was automatically measured after each extension step. Amplified transcripts
were loaded on a 2% agarose gel. CT values were automatically obtained. Relative
expression values were obtained by normalizing CT values of the tested genes in
comparison with CT values of the housekeeping genes using the  CT method.
Measurement of ROS generation
Intracellular ROS levels were measured using the fluorescent dye 27-
dichlorodihydrofluorescein diacetate (H2DCF-DA) (Molecular Probes, Eugene,
OR), which is a nonpolar compound that is converted into a nonfluorescent polar
derivative (H2DCF) by cellular esterases after incorporation into cells. H2DCF is
membrane impermeable and is rapidly oxidized to the highly fluorescent 2,7-
dichlorofluorescein (DCF) in the presence of intracellular ROS. For the experiments,
embryoid bodies were incubated in serum-free medium and 20 M H2DCF-DA
dissolved in dimethyl sulfoxide (DMSO) was added. After 20 minutes, intracellular
DCF fluorescence (corrected for background fluorescence) was evaluated in 3600
m2 regions of interest using an overlay mask unless otherwise indicated. For
fluorescence excitation, the 488 nm band of the argon ion laser of the confocal setup
was used. Emission was recorded using a longpass LP515 nm filter set.
Statistical analysis
Data are given as mean values ± s.d., with n denoting the number of experiments
unless otherwise indicated. In each experiment 15-20 embryoid bodies were
analyzed. The Student’s t-test for unpaired data was applied as appropriate. A value
of P<0.05 was considered significant.
This study was supported by the German Research Foundation
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